Related Experiment Video
Updated: Jun 6, 2026
09:11
Genome Editing with CompoZr Custom Zinc Finger Nucleases (ZFNs)
Published on: June 14, 2012
Creating designed zinc-finger nucleases with minimal cytotoxicity
Sivaprakash Ramalingam1, Karthikeyan Kandavelou, Raja Rajenderan
1Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA.
Journal of Molecular Biology
|November 25, 2010
Summary
Engineered zinc-finger nucleases (ZFNs) with modified FokI cleavage domains reduce toxicity in human cells. These obligate heterodimer variants enhance gene targeting safety and efficacy for genomic applications.
Area of Science:
- Molecular Biology
- Gene Editing Technologies
Background:
- Zinc-finger nucleases (ZFNs) are engineered DNA-binding proteins fused to FokI nuclease domains, enabling targeted genomic double-strand breaks (DSBs).
- ZFNs facilitate gene modification via homologous recombination or nonhomologous end joining in various cell types, including human cells.
- Wild-type FokI domains in ZFNs can form homodimers, potentially leading to off-target cleavage and increased cellular toxicity, limiting their therapeutic and research applications.
Purpose of the Study:
- To develop and characterize obligate heterodimer variants of the FokI cleavage domain for ZFN applications.
- To create custom ZFNs with reduced cellular toxicity and improved safety profiles.
- To assess the efficacy and efficiency of engineered ZFNs in gene targeting within human cells.
Main Methods:
- Designing and constructing obligate heterodimer variants of the FokI cleavage domain.
- Fusing engineered FokI variants to zinc-finger proteins (three-finger and four-finger domains).
- Evaluating the efficacy, efficiency, and cellular toxicity of the resulting ZFNs using a green fluorescent protein gene targeting reporter system in human cells.
Main Results:
- The obligate heterodimer variants of the FokI cleavage domain were successfully engineered.
- Specific variants, particularly three-finger and four-finger zinc-finger protein fusions with the REL_DKK pair, demonstrated significantly reduced toxicity in human cells.
- The reengineered ZFNs maintained or improved efficacy and efficiency in gene targeting reporter assays.
Conclusions:
- Obligate heterodimer FokI variants represent a significant advancement in ZFN technology, enhancing safety and reducing toxicity.
- These refined ZFNs offer a more precise and safer tool for gene editing in human cells and potential therapeutic applications.
- The developed ZFN variants minimize off-target effects, paving the way for more reliable genomic engineering strategies.
